Ranitidine hydrochloride and Pulmozyme drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine hydrochloride (ranitidine hydrochloride) and Pulmozyme (dornase alfa). Common drug interactions include pain among females and throat irritation among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine hydrochloride and Pulmozyme. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

What is Pulmozyme?

Pulmozyme has active ingredients of dornase alfa. It is often used in cystic fibrosis. eHealthMe is studying from 20,012 Pulmozyme users. Check the latest studies of Pulmozyme.

On Jul, 14, 2026

22 people who take Ranitidine hydrochloride and Pulmozyme together, and have interactions are studied.

Ranitidine hydrochloride and Pulmozyme drug interactions.

What are the common drug interactions of Ranitidine Hydrochloride and Pulmozyme, by gender? *:

female:

Pain
Arthralgia (joint pain)
Dyspnoea (difficult or laboured respiration)
Lipase increased
Nausea (feeling of having an urge to vomit)
Vomiting
Anal fissure
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Chest discomfort

male:

Throat irritation
Head injury
Hospitalisation
Infection
Lung transplant rejection (failure of lung transplant)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Pruritus (severe itching of the skin)
Pulmonary function test decreased
Wound

What are the common drug interactions of Ranitidine Hydrochloride and Pulmozyme, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Headache (pain in head)
Lung transplant rejection (failure of lung transplant)

20-29:

Nausea (feeling of having an urge to vomit)
Vomiting
Anal fissure
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Chest discomfort
Colitis ulcerative (inflammation of colon with ulcer)
Costochondritis (chest wall pain)
Cough
Decreased appetite

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Drug ineffective
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gastrointestinal pain
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 3 people, 13.64%
Lung Infection: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and Pulmozyme?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously